Straumann Holding AG

Research Straumann Holding AG (STMN) on Bullrun: market cap CHF 14.81B, P/E 40.2, dividend yield 1.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CHF 14.81B; P/E is 40.2; dividend yield is 1.1%.

Peer valuation comparison

Latest P/E is 40.22x versus a Healthcare sector median of 24.46x (64.4% above).

Latest dividend yield is 1.07% versus a Healthcare sector median of 2.11% (49.3% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CHF 2.61BCHF 355.92MCHF 280.51M68.6%2.23CHF 475.43MCHF 418.93MCHF 2.16B
FY2024CHF 2.50BCHF 388.32MCHF 315.62M71.2%2.43CHF 375.49MCHF 413.89MCHF 2.04B
FY2023CHF 2.28BCHF 246.07MCHF 316.61M74.3%1.54CHF 410.31MCHF 412.35MCHF 1.84B
FY2022CHF 2.32BCHF 434.79MCHF 219.72M75.6%2.72CHF 696.10MCHF 701.60MCHF 1.85B
FY2021n/an/an/an/a2.48n/an/an/a

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24CHF 14.81B40.21.1%1

Dividend history

Latest trailing dividend snapshot: annual dividend/share 1 CHF, yield 1.1%.

YearDividends/share
FY20250.95 CHF
FY20240.85 CHF
FY20230.8 CHF
FY20220.68 CHF
FY20210.58 CHF

About Straumann Holding AG

Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Straumann Holding AG's market cap?

Straumann Holding AG's market capitalization is CHF 14.81B.

What is Straumann Holding AG's P/E ratio?

Straumann Holding AG's price-to-earnings (P/E) ratio is 40.2.

Does Straumann Holding AG pay a dividend?

Straumann Holding AG has a dividend yield of 1.1%.

What does Straumann Holding AG do?

Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss.